These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 9236949)

  • 1. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study.
    Schneider LS; Olin JT; Doody RS; Clark CM; Morris JC; Reisberg B; Schmitt FA; Grundman M; Thomas RG; Ferris SH
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S22-32. PubMed ID: 9236949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADCS Prevention Instrument Project: ADCS-clinicians' global impression of change scales (ADCS-CGIC), self-rated and study partner-rated versions.
    Schneider LS; Clark CM; Doody R; Ferris SH; Morris JC; Raman R; Reisberg B; Schmitt FA
    Alzheimer Dis Assoc Disord; 2006; 20(4 Suppl 3):S124-38. PubMed ID: 17135806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of global change in Alzheimer's disease: identifying consensus.
    Olin JT; Schneider LS; Doody RS; Clark CM; Ferris SH; Morris JC; Reisberg B; Schmitt FA
    J Geriatr Psychiatry Neurol; 1996 Oct; 9(4):176-80. PubMed ID: 8970010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical global impressions in Alzheimer's clinical trials.
    Schneider LS; Olin JT
    Int Psychogeriatr; 1996; 8(2):277-88; discussion 288-90. PubMed ID: 8994897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of rivastigmine transdermal patch and capsule on aspects of clinical global impression of change in Alzheimer's disease: a retrospective analysis.
    Cummings JL; Ferris SH; Farlow MR; Olin JT; Meng X
    Dement Geriatr Cogn Disord; 2010; 29(5):406-12. PubMed ID: 20502014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric properties of the Alzheimer's Disease Cooperative Study - Activities of Daily Living for Mild Cognitive Impairment (ADCS-MCI-ADL) scale: a post hoc analysis of the ADCS ADC-008 trial.
    Potashman M; Pang M; Tahir M; Shahraz S; Dichter S; Perneczky R; Nolte S
    BMC Geriatr; 2023 Mar; 23(1):124. PubMed ID: 36879199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy.
    Farlow MR; Grossberg GT; Meng X; Olin J; Somogyi M
    Int J Geriatr Psychiatry; 2011 Dec; 26(12):1236-43. PubMed ID: 22068922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating Response to High-Dose 13.3 mg/24 h Rivastigmine Patch in Patients with Severe Alzheimer's Disease.
    Farlow MR; Sadowsky CH; Velting DM; Meng X; Islam MZ
    CNS Neurosci Ther; 2015 Jun; 21(6):513-9. PubMed ID: 25675992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study.
    Ferris SH; Mackell JA; Mohs R; Schneider LS; Galasko D; Whitehouse PJ; Schmitt FA; Sano M; Thomas RG; Ernesto C; Grundman M; Schafer K; Thal LJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S1-12. PubMed ID: 9236947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study.
    Mackell JA; Ferris SH; Mohs R; Schneider L; Galasko D; Whitehouse P; Schmitt F; Sano M; Thal LJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S65-9. PubMed ID: 9236955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.
    Mohs RC; Knopman D; Petersen RC; Ferris SH; Ernesto C; Grundman M; Sano M; Bieliauskas L; Geldmacher D; Clark C; Thal LJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S13-21. PubMed ID: 9236948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying behavioral disturbance in Alzheimer's disease patients.
    Weiner MF; Tractenberg R; Teri L; Logsdon R; Thomas RG; Gamst A; Thal LJ
    J Psychiatr Res; 2000; 34(2):163-7. PubMed ID: 10758259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADCS Prevention Instrument Project: overview and initial results.
    Ferris SH; Aisen PS; Cummings J; Galasko D; Salmon DP; Schneider L; Sano M; Whitehouse PJ; Edland S; Thal LJ;
    Alzheimer Dis Assoc Disord; 2006; 20(4 Suppl 3):S109-23. PubMed ID: 17135805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. The Alzheimer's Disease Cooperative Study.
    Patterson MB; Mack JL; Mackell JA; Thomas R; Tariot P; Weiner M; Whitehouse PJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S40-4. PubMed ID: 9236951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease.
    Knopman DS; Knapp MJ; Gracon SI; Davis CS
    Neurology; 1994 Dec; 44(12):2315-21. PubMed ID: 7991118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.
    Mulnard RA; Cotman CW; Kawas C; van Dyck CH; Sano M; Doody R; Koss E; Pfeiffer E; Jin S; Gamst A; Grundman M; Thomas R; Thal LJ
    JAMA; 2000 Feb; 283(8):1007-15. PubMed ID: 10697060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials.
    Galasko D; Bennett DA; Sano M; Marson D; Kaye J; Edland SD;
    Alzheimer Dis Assoc Disord; 2006; 20(4 Suppl 3):S152-69. PubMed ID: 17135809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience.
    Morris JC; Ernesto C; Schafer K; Coats M; Leon S; Sano M; Thal LJ; Woodbury P
    Neurology; 1997 Jun; 48(6):1508-10. PubMed ID: 9191756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Spanish Instrument Protocol: design and implementation of a study to evaluate treatment efficacy Instruments for Spanish-speaking patients with Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
    Sano M; Mackell JA; Ponton M; Ferreira P; Wilson J; Pawluczyk S; Pfeiffer E; Thomas RG; Jin S; Schafer K; Schittini M; Grundman M; Ferris SH; Thal LJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S57-64. PubMed ID: 9236954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.